Regeneron Pharmaceuticals
REGN
REGN
1,266 hedge funds and large institutions have $81.3B invested in Regeneron Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 182 funds opening new positions, 443 increasing their positions, 440 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% more repeat investments, than reductions
Existing positions increased: 443 | Existing positions reduced: 440
14% less funds holding in top 10
Funds holding in top 10: 29 → 25 (-4)
35% less call options, than puts
Call options by funds: $1.25B | Put options by funds: $1.93B
Holders
1,266
Holding in Top 10
25
Calls
$1.25B
Puts
$1.93B
Top Buyers
| 1 | +$1.15B | |
| 2 | +$419M | |
| 3 | +$214M | |
| 4 |
Amundi
Paris,
France
|
+$207M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$193M |
Top Sellers
| 1 | -$1.32B | |
| 2 | -$367M | |
| 3 | -$356M | |
| 4 |
BlackRock
New York
|
-$216M |
| 5 |
Neuberger Berman Group
New York
|
-$212M |